Literature DB >> 26812713

Evaluation of UVA Cytotoxicity for Human Endothelium in an Ex Vivo Corneal Cross-linking Experimental Setting.

Pepijn Mooren, Laure Gobin, Nezahat Bostan, Kristien Wouters, Nadia Zakaria, Danny G P Mathysen, Carina Koppen.   

Abstract

PURPOSE: To evaluate endothelial cytotoxicity after exposure of human corneas to ultraviolet-A (UVA) (λ = 365 nm; 5.4 J/cm(2)) in an experimental ex vivo corneal cross-linking setting.
METHODS: Sixteen pairs of human donor corneas were cut into two pieces. One piece of each cornea was treated with 0.025% riboflavin solution prior to UVA irradiation (5 minutes; 18 mW/cm(2)), whereas the other piece was not irradiated but treated with riboflavin (right eye) or preservation medium (left eye). By irradiating from the endothelial side, the UVA dosage applied to endothelial cells exceeded at least eight times the cytotoxic threshold established in animal models (0.65 J/cm(2)). Endothelial cell counts were performed by two independent investigators after storage (4 to 5 days at 31 °C) and staining (trypan blue, alizarin red). Normality (Q-Q plot; Shapiro-Wilk test) and equivalence (mixed-effects modeling with a 10% equivalence threshold) of the endothelial cell counts of the different groups were evaluated.
RESULTS: Equivalence of mean endothelial cell density between both groups was observed: 2,237 ± 208 cells/mm(2) in UVA-irradiated pieces and 2,290 ± 281 cells/mm(2) in control pieces (mean difference of 53 ± 240 cells/mm(2) between both groups).
CONCLUSIONS: Despite direct irradiation of human donor endothelium using the clinical dosage for cross-linking, equivalence in endothelial cell counts was observed between irradiated tissues and controls. Ex vivo human corneal endothelial cells seem to be far more resistant to riboflavin-enhanced UVA irradiation than previously estimated by animal experiments. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26812713     DOI: 10.3928/1081597X-20151207-05

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

Review 1.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

2.  Essential role of ultraviolet radiation in the decrease of corneal endothelial cell density caused by pterygium.

Authors:  Xia Li; Yiqin Dai; Weiwei Xu; Jianjiang Xu
Journal:  Eye (Lond)       Date:  2018-08-29       Impact factor: 3.775

3.  Decreased Riboflavin Impregnation Time Does Not Increase the Risk for Endothelial Phototoxicity During Corneal Cross-Linking.

Authors:  Arie L Marcovich; Jurriaan Brekelmans; Alexander Brandis; Ilan Samish; Iddo Pinkas; Dina Preise; Keren Sasson; Ilan Feine; Alexandra Goz; Mor M Dickman; Rudy M M A Nuijts; Avigdor Scherz
Journal:  Transl Vis Sci Technol       Date:  2020-05-11       Impact factor: 3.283

4.  Is Pterygium Morphology Related to Loss of Corneal Endothelial Cells? A Cross-Sectional Study.

Authors:  Syed Bilal Hassan Zaidi; Wajid Ali Khan
Journal:  Clin Ophthalmol       Date:  2021-03-23

Review 5.  Biomechanics of Ophthalmic Crosslinking.

Authors:  Brecken J Blackburn; Andrew M Rollins; William J Dupps
Journal:  Transl Vis Sci Technol       Date:  2021-04-29       Impact factor: 3.283

6.  Multi modal imaging in corneal edema after corneal collagen cross-linking (CXL); a case-based literature review.

Authors:  Mohammad Soleimani; Zohre Ebrahimi; Mohammad Yazdani Moghadam; Mansoor Shahriari; Sara Behzadfar; Bahareh Ramezani; Kasra Cheraqpour
Journal:  BMC Ophthalmol       Date:  2021-12-24       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.